Bladder injury during rectal surgery- a video vign by Corrado R . Asteria
Colorectal Disease, 2019
We present a case of an intraperitoneal bladder injury during laparoscopic rectal surgery for pel... more We present a case of an intraperitoneal bladder injury during laparoscopic rectal surgery for pelvic organ prolapse.
British Journal of Surgery, 2019
BACKGROUND:
Colonic J pouch reconstruction has been found to be associated with a lower incidenc... more BACKGROUND:
Colonic J pouch reconstruction has been found to be associated with a lower incidence of anastomotic leakage than straight anastomosis. However, studies on this topic are underpowered and retrospective. This randomized trial evaluated whether the incidence of anastomotic leakage was reduced after colonic J pouch reconstruction compared with straight colorectal anastomosis following anterior resection for rectal cancer.
METHODS:
This multicentre RCT included patients with rectal carcinoma who underwent low anterior resection followed by colorectal anastomosis. Patients were assigned randomly to receive a colonic J pouch or straight colorectal anastomosis. The main outcome measure was the occurrence of major anastomotic leakage. The incidence of global (major plus minor) anastomotic leakage and general complications were secondary outcomes. Risk factors for anastomotic leakage were identified by regression analysis.
RESULTS:
Of 457 patients enrolled, 379 were evaluable (colonic J pouch arm 190, straight colorectal arm 189). The incidence of major and global anastomotic leakage, and general complications was 14·2, 19·5 and 34·2 per cent respectively in the colonic J pouch group, and 12·2, 19·0 and 27·0 per cent in the straight colorectal anastomosis group. No statistically significant differences were observed between the two arms. In multivariable logistic regression analysis, male sex (odds ratio 1·79, 95 per cent c.i. 1·02 to 3·15; P = 0·042) and high ASA fitness grade (odds ratio 2·06, 1·15 to 3·71; P = 0·015) were independently associated with the occurrence of anastomotic leakage.
CONCLUSION:
Colonic J pouch reconstruction does not reduce the incidence of anastomotic leakage and postoperative complications compared with conventional straight colorectal anastomosis. Registration number NCT01110798 (http://www.clinicaltrials.gov).
Colorectal Dis, 2019
AIM:
There is considerable heterogeneity in outcomes in studies reporting on treatment of haemor... more AIM:
There is considerable heterogeneity in outcomes in studies reporting on treatment of haemorrhoidal disease (HD). The aim of this study was to develop a Core Outcome Set (COS) for HD in cooperation with the European Society of Coloproctology (ESCP).
METHOD:
A Delphi study was performed according to the OMERACT methodology. In total 38 healthcare professionals and 30 patients were invited to the panel. Previously, 10 outcome Domains and 59 Outcomes were identified through a systematic literature review. In this study these Domains and Outcomes were created into one questionnaire for healthcare professionals and a separate questionnaire for patients. Sequential questionnaire rounds prioritizing the Domains and Outcomes were conducted. Panel members were asked to rate the appropriateness of each Domain and Outcome on a 9-point Likert scale. During a face-to-face meeting, healthcare professionals agreed on the primary and secondary endpoints of the COS for HD. Finally, a short survey was sent to the healthcare professionals in order to reach consensus on how the chosen endpoints should be assessed and at which time points.
RESULTS:
The response rate in questionnaire round 1 for healthcare professionals was 44.7% (n=17). Sixteen out of seventeen healthcare professionals also completed the questionnaire in round 2. The response rate for the patient questionnaire was 60% (n=18). Seventeen healthcare professionals participated in the face-to-face meeting. The questionnaire rounds did not result in a clear-cut selection of primary and secondary endpoints. Most Domains and Outcomes were considered important and only three Outcomes were excluded. During the face-to-face meeting, agreement was reached to select the Domain 'symptoms' as primary endpoints, and 'complications', 'recurrence' and 'patient satisfaction' as secondary endpoints in the COS for HD. Furthermore, consensus was reached that the Domain 'symptoms' should be a Patient Reported Outcome Measure and include the Outcomes 'pain' and 'prolapse', 'itching', 'soiling' and 'blood loss'. The Domain 'complications' should include the Outcomes 'incontinence', 'abscess', 'urinary retention', 'anal stenosis' and 'fistula'. Consensus was reached to use 'reappearance of initial symptoms' as reported by the patient to define recurrence. During an additional short survey, consensus was reached that 'incontinence' should be assessed by the Wexner Fecal Incontinence Score, 'abscess' by physical examination, 'urinary retention' by ultrasonography, 'anal stenosis' by physical examination, and 'fistula' by physical examination and MR imaging if inconclusive. During follow-up, the Outcome 'symptoms' should be assessed at baseline, 7 days, 6 weeks and one year post-procedure. The Outcomes 'abscess' and 'urinary retention' should be assessed 7 days post-procedure and 'incontinence', 'anal stenosis' and 'fistula' one year post-procedure.
CONCLUSIONS:
We developed the first European Society of Coloproctology (ESCP) Core Outcome Set for haemorrhoidal disease based on an international Delphi study among healthcare professionals. The next step is to incorporate the patients' perspective in the COS. Use of this COS may improve the quality and uniformity of future research and enhance the analysis of evidence. This article is protected by copyright. All rights reserved.
L'Ateneo parmense. Acta bio-medica : organo della Società di medicina e scienze naturali di Parma, 1978
A series of 25 cases of Serratia infections, during the period from november 1977 through aptile ... more A series of 25 cases of Serratia infections, during the period from november 1977 through aptile 1978, is reported. Serratia isolates were identified with increasing frequency from urine, surgical incisions and blood. All the patients had received antimicrobial therapy prior to the time Serratia was first isolated. These patients (92%) had had indwelling urinary catheters inserted during the post-operative course and Serratia was isolated predominantly from the urinary tract. In 3 patients who died, Serratia played a role in the ultimate demise of the patient. Prophylaxix and antimicrobial therapy are discussed.
Colorectal Dis, 2017
Background: Anastomosis method following right sided colonic resection is widely variable
Tech Coloproctol, 2017
BACKGROUND:
Rectum-sparing approaches appear to be appropriate in rectal cancer patients with a ... more BACKGROUND:
Rectum-sparing approaches appear to be appropriate in rectal cancer patients with a major (mCR) or complete clinical response (cCR) after neoadjuvant therapy. The aim of the present study is to evaluate the effectiveness of rectum-sparing approaches at 2 years after the completion of neoadjuvant treatment.
STUDY DESIGN:
Patients with rectal adenocarcinoma eligible to receive neoadjuvant therapy will be prospectively enrolled. Patients will be restaged 7-8 weeks after the completion of neoadjuvant therapy and those with mCR (defined as absence of mass, small mucosal irregularity no more than 2 cm in diameter at endoscopy and no metastatic nodes at MRI) or cCR will be enrolled in the trial. Patients with mCR will undergo local excision, while patients with cCR will either undergo local excision or watch and wait policy. The main end point of the study is to determine the percentage of rectum preservation at 2 years in the enrolled patients.
CONCLUSION:
This protocol is the first prospective trial that investigates the role of both local excision and watch and wait approaches in patients treated with neoadjuvant therapy for rectal cancer. The trial is registered at clinicaltrials.gov (NCT02710812).
Colorectal Dis, 2017
Background: Patient and disease-related factors, as well as operation technique all have the
Eur J Cancer Prev, 2017
The rates of colorectal cancer (CRC) interval surveyed in screen-detected patients using a fecal ... more The rates of colorectal cancer (CRC) interval surveyed in screen-detected patients using a fecal immunochemical test (FIT) are not negligible. The aim of this study was to assess the effect of interval cancer on outcomes compared with a population with cancer diagnosed after a positive test result. All patients between 50 and 71 years of age, who were residents of the Mantua district, affected by CRC and operated on from 2005 to 2010 were reviewed. Other than patient-related, disease-related, and treatment-related factors and tumor location, this population was differentiated as either participating or not to screening and then into populations developing interval cancer after a negative FIT result. Mortality was investigated by univariate analysis and by overall survival rates. The mean age of the 975 patients enrolled was 62 years (61.7% males). Most patients (n = 575, 59%) were not screen detected, and 400 (41%) were screen detected. Fifty-six (5.7%) patients in the latter group, representing 14% of the participants, developed interval cancer after a negative FIT result. Their cancer was mostly localized in the right colon (41.1%) instead of the left colon and rectum (P = 0.02). They also showed higher stages (P = 0.001), a moderate degree of differentiation (P = 0.001), and overall higher mortality rates than patients with cancer diagnosed after a positive test result (P = 0.001). The effect of interval CRC after screening with FIT resulted in worse outcomes compared with the FIT-positive group. With such findings, patients who had negative results for FIT should be informed of the risk of developing cancer within the rounds of screening to independently gain educational skills in the area of health prevention. European Journal of Cancer Prevention 00:000–000
Eur J PLastic Surg, 2018
A horseshoe perianal skin melanoma was treated by cutaneous advancement flap (Y-V shaped) and the... more A horseshoe perianal skin melanoma was treated by cutaneous advancement flap (Y-V shaped) and the outcome was investigated
over a long-term follow-up. Objects of investigation were the history taking, the preoperative work-up, the adopted surgical
procedure, and the histological and immune-histochemical findings concerning additional lesions found during the follow-up. The
follow-up lasted 140 months. In this patient, a previous breast cancer was diagnosed and treated. Local diffusion of soft tissue, nodes,
and anal sphincter infiltration or distant metastasis were not shown preoperatively. Awide excision with an advancement flap Y-V
was carried out. Histological findings showed a level II of Clark with Breslow 0.65 mm. No local or distant recurrences were found
by follow-up. Sixty months later, two pigmented lesions (0.3 0.2 mm) were detected and removed. Histologically, a hyperpigmentation
of the basal layer of epidermis and immunostaining with Melan-A and CD 117 confirmed the absence of any significant
melanocytic proliferation. Ninety months after the first procedure, a new small cell carcinoma of the right lung was detected leading
the patient to death after 140 months. The findings of this report raise issues related to plastic and reconstructive modality but also to
oncological outcome. We were also able to recognize a possible compromised immune deficiency over a considerable life span.
However, the occurrence of melanoma did not affect the unfavorable outcome, which was caused by other cancers.
Level of Evidence: Level V, prognostic study
Colorectal Dis, 2018
Aim The management of haemorrhoids has changed significantly in the last two decades as a result ... more Aim The management of haemorrhoids has changed significantly in the last two decades as a result of new insights into their pathophysiology and the availability of new surgical devices. The aim of this survey was to evaluate changes in the management of haemorrhoids in Italy over the last 17 years.
Minerva Chir, 2018
BACKGROUND:
To assess outcomes of patients operated on for rectal cancer (RC) by analysing the t... more BACKGROUND:
To assess outcomes of patients operated on for rectal cancer (RC) by analysing the trends of disease free survival curves (DFSc) after a very long-term follow-up.
METHODS:
All patients treated with curative intent for RC from 1986 to 2005 were retrospectively analyzed. Other than demographics, disease characteristics and treatment-related factors were considered. The DFSc were compared between patients who had neoadjuvant therapy (NAT) and those who had surgery alone.
RESULTS:
Median age of 319 patients included in the study was 66.3 years (range 23-89) and 140 (57.6%) of them were males. Moreover, NAT was given in 24 (11.8%) patients, and adjuvant therapy in 40 (19.7%) patients. Median follow-up was of 150 months (60-240). In patients who had NAT the mean age was higher (P=0.05), RC were located lower (P=0.009) and higher positive lymph-nodes were found (P=0.003), whereas the number of both local (P=0.4) and distant recurrences (P=0.7) was not significantly lower, compared to the other group. Comparing trends of DFSc a more progressive decrease was shown in patients treated with surgery alone. Even if the differences of DSFc between groups at the end of follow-up were not significant (95% CI: 0.609-2.963, P=0.46), patients who had NAT displayed better survival up to 180 months.
CONCLUSIONS:
Overall, these results showed comparable outcomes between both groups over such a long lasting follow-up. This time frame might be used more extensively for increasing our knowledge of RC biological behaviour as well.
a B S T r a C T BaCKgrOuND: To assess outcomes of patients operated on for rectal cancer (rC) by ... more a B S T r a C T BaCKgrOuND: To assess outcomes of patients operated on for rectal cancer (rC) by analysing the trends of disease free survival curves (DFSc) after a very long-term follow-up. MeThODS: all patients treated with curative intent for rC from 1986 to 2005 were retrospectively analyzed. Other than demographics, disease characteristics and treatment-related factors were considered. The DFSc were compared between patients who had neoadjuvant therapy (NaT) and those who had surgery alone. reSuLTS: Median age of 319 patients included in the study was 66.3 years (range 23-89) and 140 (57.6%) of them were males. Moreover, NaT was given in 24 (11.8%) patients, and adjuvant therapy in 40 (19.7%) patients. Median follow-up was of 150 months (60-240). in patients who had NaT the mean age was higher (P=0.05), rC were located lower (P=0.009) and higher positive lymph-nodes were found (P=0.003), whereas the number of both local (P=0.4) and distant recurrences (P=0.7) was not significantly lower, compared to the other group. Comparing trends of DFSc a more progressive decrease was shown in patients treated with surgery alone. even if the differences of DSFc between groups at the end of follow-up were not significant (95% CI: 0.609-2.963, P=0.46), patients who had NAT displayed better survival up to 180 months. CONCLuSiONS: Overall, these results showed comparable outcomes between both groups over such a long lasting follow-up. This time frame might be used more extensively for increasing our knowledge of rC biological behaviour as well.
Colorectal Dis, 2018
Article type: Observational cohort study Abstract Background
Colorectal Dis, 2018
An international multicentre prospective audit of elective rectal cancer surgery; operative appro... more An international multicentre prospective audit of elective rectal cancer surgery; operative approach versus outcome, including transanal total mesorectal excision (TaTME) Abstract Introduction Transanal total mesorectal excision (TaTME) has rapidly emerged as a novel approach for rectal cancer surgery. Safety profiles are still emerging and more comparative data is urgently needed. This study aimed to compare indications and short-term outcomes of TaTME, open, laparoscopic, and robotic TME internationally.
Colorectal Dis, 2018
Background Laparoscopy has now been implemented as a standard of care for elective colonic resect... more Background Laparoscopy has now been implemented as a standard of care for elective colonic resection around the world. During the adoption period, studies showed that conversion may be detrimental to patients, with poorer outcomes than both laparoscopic completed or planned open surgery. The primary aim of this study was to determine whether laparoscopic conversion was associated with a higher major complication rate than planned open surgery in contemporary, international practice.
Colorectal Dis, 2018
Introduction The optimal bowel preparation strategy to minimise the risk of anastomotic leak is y... more Introduction The optimal bowel preparation strategy to minimise the risk of anastomotic leak is yet to be determined. This study aimed to determine whether oral antibiotics combined with mechanical bowel preparation (MBP+Abx) was associated with a reduced risk of anastomotic leak when compared to mechanical bowel preparation alone (MBP) or no bowel preparation (NBP).
Colorectal Dis, 2018
Introduction The mainstay of management for locally advanced rectal cancer is chemoradiotherapy f... more Introduction The mainstay of management for locally advanced rectal cancer is chemoradiotherapy followed by surgical resection. Following chemoradiotherapy, a complete response may be detected clinically and radiologically (cCR) prior to surgery or pathologically after surgery (pCR). We aim to report the overall complete pathological response (pCR) rate and the reliability of detecting a cCR by conventional pre-operative imaging.
Colorectal Dis , 2018
Introduction Some evidence suggests that primary anastomosis following left sided colorectal rese... more Introduction Some evidence suggests that primary anastomosis following left sided colorectal resection in the emergency setting may be safe in selected patients, and confer favourable outcomes to permanent enteros-tomy. The aim of this study was to compare the major postoperative complication rate in patients undergoing end stoma vs primary anastomosis following emergency left sided colorectal resection.
Background The aim of this study was to identify risk factors for lymph node positivity in T1 col... more Background The aim of this study was to identify risk factors for lymph node positivity in T1 colon cancer and to carry out a surgical quality assurance audit. Methods The sample consisted of consecutive patients treated for early-stage colon lesions in 15 colorectal referral centres between 2011 and 2014. The study investigated 38 factors grouped into four categories: demographic information, preoperative data, indications for surgery and post-operative data. A univariate and
multivariate logistic regression analysis was performed to analyze the significance of each factor both in terms of lymph node (LN) harvesting and LN metastases. Results Out of 507 patients enrolled, 394 patients were considered for analysis. Thirty-five (8.91%) patients had positive LN. Statistically significant differences related to total LN harvesting were found in relation to central vessel ligation and segmental resections. Cumulative distribution demonstrated that the rate of positive LN increased starting at 12 LN harvested and reached a plateau at 25 LN.
Minerva chirurgica
Two cases of gastric leiomyoblastoma (one of which of exceptional size, measuring more than 40 cm... more Two cases of gastric leiomyoblastoma (one of which of exceptional size, measuring more than 40 cm) observed respectively in 1992 at the Surgery Division of USSL 45 at Asola (MN) and in 1990 at the Second Surgery Division of USSL 47 in Mantova are reported. In the first case anaemia revealed the tumor whereas in the second case the patient suffering from a pain in the abdomen was admitted to hospital. These two tumors raise interest for their rarity and for their uncertain biological evolution. They generally develop very slowly and tend to remain intramural. The most frequently attacked seats are the antum-pyloric region and the stomach body. The main symptoms are epigastric pain, nausea, vomiting, weight loss, sideropenic anaemia, epigastric palpable mass. The diagnostic iter includes radiologic examination (digestive tube X-ray, echography, TAC, arteriography), gastroscopy and laparoscopy. In most cases surgical resection is not completely destroying, except for those cases in whi...
Uploads
Bladder injury during rectal surgery- a video vign by Corrado R . Asteria
Colonic J pouch reconstruction has been found to be associated with a lower incidence of anastomotic leakage than straight anastomosis. However, studies on this topic are underpowered and retrospective. This randomized trial evaluated whether the incidence of anastomotic leakage was reduced after colonic J pouch reconstruction compared with straight colorectal anastomosis following anterior resection for rectal cancer.
METHODS:
This multicentre RCT included patients with rectal carcinoma who underwent low anterior resection followed by colorectal anastomosis. Patients were assigned randomly to receive a colonic J pouch or straight colorectal anastomosis. The main outcome measure was the occurrence of major anastomotic leakage. The incidence of global (major plus minor) anastomotic leakage and general complications were secondary outcomes. Risk factors for anastomotic leakage were identified by regression analysis.
RESULTS:
Of 457 patients enrolled, 379 were evaluable (colonic J pouch arm 190, straight colorectal arm 189). The incidence of major and global anastomotic leakage, and general complications was 14·2, 19·5 and 34·2 per cent respectively in the colonic J pouch group, and 12·2, 19·0 and 27·0 per cent in the straight colorectal anastomosis group. No statistically significant differences were observed between the two arms. In multivariable logistic regression analysis, male sex (odds ratio 1·79, 95 per cent c.i. 1·02 to 3·15; P = 0·042) and high ASA fitness grade (odds ratio 2·06, 1·15 to 3·71; P = 0·015) were independently associated with the occurrence of anastomotic leakage.
CONCLUSION:
Colonic J pouch reconstruction does not reduce the incidence of anastomotic leakage and postoperative complications compared with conventional straight colorectal anastomosis. Registration number NCT01110798 (http://www.clinicaltrials.gov).
There is considerable heterogeneity in outcomes in studies reporting on treatment of haemorrhoidal disease (HD). The aim of this study was to develop a Core Outcome Set (COS) for HD in cooperation with the European Society of Coloproctology (ESCP).
METHOD:
A Delphi study was performed according to the OMERACT methodology. In total 38 healthcare professionals and 30 patients were invited to the panel. Previously, 10 outcome Domains and 59 Outcomes were identified through a systematic literature review. In this study these Domains and Outcomes were created into one questionnaire for healthcare professionals and a separate questionnaire for patients. Sequential questionnaire rounds prioritizing the Domains and Outcomes were conducted. Panel members were asked to rate the appropriateness of each Domain and Outcome on a 9-point Likert scale. During a face-to-face meeting, healthcare professionals agreed on the primary and secondary endpoints of the COS for HD. Finally, a short survey was sent to the healthcare professionals in order to reach consensus on how the chosen endpoints should be assessed and at which time points.
RESULTS:
The response rate in questionnaire round 1 for healthcare professionals was 44.7% (n=17). Sixteen out of seventeen healthcare professionals also completed the questionnaire in round 2. The response rate for the patient questionnaire was 60% (n=18). Seventeen healthcare professionals participated in the face-to-face meeting. The questionnaire rounds did not result in a clear-cut selection of primary and secondary endpoints. Most Domains and Outcomes were considered important and only three Outcomes were excluded. During the face-to-face meeting, agreement was reached to select the Domain 'symptoms' as primary endpoints, and 'complications', 'recurrence' and 'patient satisfaction' as secondary endpoints in the COS for HD. Furthermore, consensus was reached that the Domain 'symptoms' should be a Patient Reported Outcome Measure and include the Outcomes 'pain' and 'prolapse', 'itching', 'soiling' and 'blood loss'. The Domain 'complications' should include the Outcomes 'incontinence', 'abscess', 'urinary retention', 'anal stenosis' and 'fistula'. Consensus was reached to use 'reappearance of initial symptoms' as reported by the patient to define recurrence. During an additional short survey, consensus was reached that 'incontinence' should be assessed by the Wexner Fecal Incontinence Score, 'abscess' by physical examination, 'urinary retention' by ultrasonography, 'anal stenosis' by physical examination, and 'fistula' by physical examination and MR imaging if inconclusive. During follow-up, the Outcome 'symptoms' should be assessed at baseline, 7 days, 6 weeks and one year post-procedure. The Outcomes 'abscess' and 'urinary retention' should be assessed 7 days post-procedure and 'incontinence', 'anal stenosis' and 'fistula' one year post-procedure.
CONCLUSIONS:
We developed the first European Society of Coloproctology (ESCP) Core Outcome Set for haemorrhoidal disease based on an international Delphi study among healthcare professionals. The next step is to incorporate the patients' perspective in the COS. Use of this COS may improve the quality and uniformity of future research and enhance the analysis of evidence. This article is protected by copyright. All rights reserved.
Rectum-sparing approaches appear to be appropriate in rectal cancer patients with a major (mCR) or complete clinical response (cCR) after neoadjuvant therapy. The aim of the present study is to evaluate the effectiveness of rectum-sparing approaches at 2 years after the completion of neoadjuvant treatment.
STUDY DESIGN:
Patients with rectal adenocarcinoma eligible to receive neoadjuvant therapy will be prospectively enrolled. Patients will be restaged 7-8 weeks after the completion of neoadjuvant therapy and those with mCR (defined as absence of mass, small mucosal irregularity no more than 2 cm in diameter at endoscopy and no metastatic nodes at MRI) or cCR will be enrolled in the trial. Patients with mCR will undergo local excision, while patients with cCR will either undergo local excision or watch and wait policy. The main end point of the study is to determine the percentage of rectum preservation at 2 years in the enrolled patients.
CONCLUSION:
This protocol is the first prospective trial that investigates the role of both local excision and watch and wait approaches in patients treated with neoadjuvant therapy for rectal cancer. The trial is registered at clinicaltrials.gov (NCT02710812).
over a long-term follow-up. Objects of investigation were the history taking, the preoperative work-up, the adopted surgical
procedure, and the histological and immune-histochemical findings concerning additional lesions found during the follow-up. The
follow-up lasted 140 months. In this patient, a previous breast cancer was diagnosed and treated. Local diffusion of soft tissue, nodes,
and anal sphincter infiltration or distant metastasis were not shown preoperatively. Awide excision with an advancement flap Y-V
was carried out. Histological findings showed a level II of Clark with Breslow 0.65 mm. No local or distant recurrences were found
by follow-up. Sixty months later, two pigmented lesions (0.3 0.2 mm) were detected and removed. Histologically, a hyperpigmentation
of the basal layer of epidermis and immunostaining with Melan-A and CD 117 confirmed the absence of any significant
melanocytic proliferation. Ninety months after the first procedure, a new small cell carcinoma of the right lung was detected leading
the patient to death after 140 months. The findings of this report raise issues related to plastic and reconstructive modality but also to
oncological outcome. We were also able to recognize a possible compromised immune deficiency over a considerable life span.
However, the occurrence of melanoma did not affect the unfavorable outcome, which was caused by other cancers.
Level of Evidence: Level V, prognostic study
To assess outcomes of patients operated on for rectal cancer (RC) by analysing the trends of disease free survival curves (DFSc) after a very long-term follow-up.
METHODS:
All patients treated with curative intent for RC from 1986 to 2005 were retrospectively analyzed. Other than demographics, disease characteristics and treatment-related factors were considered. The DFSc were compared between patients who had neoadjuvant therapy (NAT) and those who had surgery alone.
RESULTS:
Median age of 319 patients included in the study was 66.3 years (range 23-89) and 140 (57.6%) of them were males. Moreover, NAT was given in 24 (11.8%) patients, and adjuvant therapy in 40 (19.7%) patients. Median follow-up was of 150 months (60-240). In patients who had NAT the mean age was higher (P=0.05), RC were located lower (P=0.009) and higher positive lymph-nodes were found (P=0.003), whereas the number of both local (P=0.4) and distant recurrences (P=0.7) was not significantly lower, compared to the other group. Comparing trends of DFSc a more progressive decrease was shown in patients treated with surgery alone. Even if the differences of DSFc between groups at the end of follow-up were not significant (95% CI: 0.609-2.963, P=0.46), patients who had NAT displayed better survival up to 180 months.
CONCLUSIONS:
Overall, these results showed comparable outcomes between both groups over such a long lasting follow-up. This time frame might be used more extensively for increasing our knowledge of RC biological behaviour as well.
multivariate logistic regression analysis was performed to analyze the significance of each factor both in terms of lymph node (LN) harvesting and LN metastases. Results Out of 507 patients enrolled, 394 patients were considered for analysis. Thirty-five (8.91%) patients had positive LN. Statistically significant differences related to total LN harvesting were found in relation to central vessel ligation and segmental resections. Cumulative distribution demonstrated that the rate of positive LN increased starting at 12 LN harvested and reached a plateau at 25 LN.
Colonic J pouch reconstruction has been found to be associated with a lower incidence of anastomotic leakage than straight anastomosis. However, studies on this topic are underpowered and retrospective. This randomized trial evaluated whether the incidence of anastomotic leakage was reduced after colonic J pouch reconstruction compared with straight colorectal anastomosis following anterior resection for rectal cancer.
METHODS:
This multicentre RCT included patients with rectal carcinoma who underwent low anterior resection followed by colorectal anastomosis. Patients were assigned randomly to receive a colonic J pouch or straight colorectal anastomosis. The main outcome measure was the occurrence of major anastomotic leakage. The incidence of global (major plus minor) anastomotic leakage and general complications were secondary outcomes. Risk factors for anastomotic leakage were identified by regression analysis.
RESULTS:
Of 457 patients enrolled, 379 were evaluable (colonic J pouch arm 190, straight colorectal arm 189). The incidence of major and global anastomotic leakage, and general complications was 14·2, 19·5 and 34·2 per cent respectively in the colonic J pouch group, and 12·2, 19·0 and 27·0 per cent in the straight colorectal anastomosis group. No statistically significant differences were observed between the two arms. In multivariable logistic regression analysis, male sex (odds ratio 1·79, 95 per cent c.i. 1·02 to 3·15; P = 0·042) and high ASA fitness grade (odds ratio 2·06, 1·15 to 3·71; P = 0·015) were independently associated with the occurrence of anastomotic leakage.
CONCLUSION:
Colonic J pouch reconstruction does not reduce the incidence of anastomotic leakage and postoperative complications compared with conventional straight colorectal anastomosis. Registration number NCT01110798 (http://www.clinicaltrials.gov).
There is considerable heterogeneity in outcomes in studies reporting on treatment of haemorrhoidal disease (HD). The aim of this study was to develop a Core Outcome Set (COS) for HD in cooperation with the European Society of Coloproctology (ESCP).
METHOD:
A Delphi study was performed according to the OMERACT methodology. In total 38 healthcare professionals and 30 patients were invited to the panel. Previously, 10 outcome Domains and 59 Outcomes were identified through a systematic literature review. In this study these Domains and Outcomes were created into one questionnaire for healthcare professionals and a separate questionnaire for patients. Sequential questionnaire rounds prioritizing the Domains and Outcomes were conducted. Panel members were asked to rate the appropriateness of each Domain and Outcome on a 9-point Likert scale. During a face-to-face meeting, healthcare professionals agreed on the primary and secondary endpoints of the COS for HD. Finally, a short survey was sent to the healthcare professionals in order to reach consensus on how the chosen endpoints should be assessed and at which time points.
RESULTS:
The response rate in questionnaire round 1 for healthcare professionals was 44.7% (n=17). Sixteen out of seventeen healthcare professionals also completed the questionnaire in round 2. The response rate for the patient questionnaire was 60% (n=18). Seventeen healthcare professionals participated in the face-to-face meeting. The questionnaire rounds did not result in a clear-cut selection of primary and secondary endpoints. Most Domains and Outcomes were considered important and only three Outcomes were excluded. During the face-to-face meeting, agreement was reached to select the Domain 'symptoms' as primary endpoints, and 'complications', 'recurrence' and 'patient satisfaction' as secondary endpoints in the COS for HD. Furthermore, consensus was reached that the Domain 'symptoms' should be a Patient Reported Outcome Measure and include the Outcomes 'pain' and 'prolapse', 'itching', 'soiling' and 'blood loss'. The Domain 'complications' should include the Outcomes 'incontinence', 'abscess', 'urinary retention', 'anal stenosis' and 'fistula'. Consensus was reached to use 'reappearance of initial symptoms' as reported by the patient to define recurrence. During an additional short survey, consensus was reached that 'incontinence' should be assessed by the Wexner Fecal Incontinence Score, 'abscess' by physical examination, 'urinary retention' by ultrasonography, 'anal stenosis' by physical examination, and 'fistula' by physical examination and MR imaging if inconclusive. During follow-up, the Outcome 'symptoms' should be assessed at baseline, 7 days, 6 weeks and one year post-procedure. The Outcomes 'abscess' and 'urinary retention' should be assessed 7 days post-procedure and 'incontinence', 'anal stenosis' and 'fistula' one year post-procedure.
CONCLUSIONS:
We developed the first European Society of Coloproctology (ESCP) Core Outcome Set for haemorrhoidal disease based on an international Delphi study among healthcare professionals. The next step is to incorporate the patients' perspective in the COS. Use of this COS may improve the quality and uniformity of future research and enhance the analysis of evidence. This article is protected by copyright. All rights reserved.
Rectum-sparing approaches appear to be appropriate in rectal cancer patients with a major (mCR) or complete clinical response (cCR) after neoadjuvant therapy. The aim of the present study is to evaluate the effectiveness of rectum-sparing approaches at 2 years after the completion of neoadjuvant treatment.
STUDY DESIGN:
Patients with rectal adenocarcinoma eligible to receive neoadjuvant therapy will be prospectively enrolled. Patients will be restaged 7-8 weeks after the completion of neoadjuvant therapy and those with mCR (defined as absence of mass, small mucosal irregularity no more than 2 cm in diameter at endoscopy and no metastatic nodes at MRI) or cCR will be enrolled in the trial. Patients with mCR will undergo local excision, while patients with cCR will either undergo local excision or watch and wait policy. The main end point of the study is to determine the percentage of rectum preservation at 2 years in the enrolled patients.
CONCLUSION:
This protocol is the first prospective trial that investigates the role of both local excision and watch and wait approaches in patients treated with neoadjuvant therapy for rectal cancer. The trial is registered at clinicaltrials.gov (NCT02710812).
over a long-term follow-up. Objects of investigation were the history taking, the preoperative work-up, the adopted surgical
procedure, and the histological and immune-histochemical findings concerning additional lesions found during the follow-up. The
follow-up lasted 140 months. In this patient, a previous breast cancer was diagnosed and treated. Local diffusion of soft tissue, nodes,
and anal sphincter infiltration or distant metastasis were not shown preoperatively. Awide excision with an advancement flap Y-V
was carried out. Histological findings showed a level II of Clark with Breslow 0.65 mm. No local or distant recurrences were found
by follow-up. Sixty months later, two pigmented lesions (0.3 0.2 mm) were detected and removed. Histologically, a hyperpigmentation
of the basal layer of epidermis and immunostaining with Melan-A and CD 117 confirmed the absence of any significant
melanocytic proliferation. Ninety months after the first procedure, a new small cell carcinoma of the right lung was detected leading
the patient to death after 140 months. The findings of this report raise issues related to plastic and reconstructive modality but also to
oncological outcome. We were also able to recognize a possible compromised immune deficiency over a considerable life span.
However, the occurrence of melanoma did not affect the unfavorable outcome, which was caused by other cancers.
Level of Evidence: Level V, prognostic study
To assess outcomes of patients operated on for rectal cancer (RC) by analysing the trends of disease free survival curves (DFSc) after a very long-term follow-up.
METHODS:
All patients treated with curative intent for RC from 1986 to 2005 were retrospectively analyzed. Other than demographics, disease characteristics and treatment-related factors were considered. The DFSc were compared between patients who had neoadjuvant therapy (NAT) and those who had surgery alone.
RESULTS:
Median age of 319 patients included in the study was 66.3 years (range 23-89) and 140 (57.6%) of them were males. Moreover, NAT was given in 24 (11.8%) patients, and adjuvant therapy in 40 (19.7%) patients. Median follow-up was of 150 months (60-240). In patients who had NAT the mean age was higher (P=0.05), RC were located lower (P=0.009) and higher positive lymph-nodes were found (P=0.003), whereas the number of both local (P=0.4) and distant recurrences (P=0.7) was not significantly lower, compared to the other group. Comparing trends of DFSc a more progressive decrease was shown in patients treated with surgery alone. Even if the differences of DSFc between groups at the end of follow-up were not significant (95% CI: 0.609-2.963, P=0.46), patients who had NAT displayed better survival up to 180 months.
CONCLUSIONS:
Overall, these results showed comparable outcomes between both groups over such a long lasting follow-up. This time frame might be used more extensively for increasing our knowledge of RC biological behaviour as well.
multivariate logistic regression analysis was performed to analyze the significance of each factor both in terms of lymph node (LN) harvesting and LN metastases. Results Out of 507 patients enrolled, 394 patients were considered for analysis. Thirty-five (8.91%) patients had positive LN. Statistically significant differences related to total LN harvesting were found in relation to central vessel ligation and segmental resections. Cumulative distribution demonstrated that the rate of positive LN increased starting at 12 LN harvested and reached a plateau at 25 LN.